Search Results

The Bruker Daltonics, Inc. MALDI Biotyper CA System is a mass spectrometer system using matrix-assisted laser desorption/ionization – time-of-flight (MALDI-TOF) for the identification of microorganisms cultured from human specimens.

The MALDI Biotyper CA System is a qualitative in vitro diagnostic device indicated for use in conjunction with other clinical and laboratory findings to aid in the diagnosis of bacterial and yeast infections.

The Bruker Daltonics, Inc. MALDI Biotyper CA System is a mass spectrometer system using matrix-assisted laser desorption/ionization – time-of-flight (MALDI-TOF) for the identification of microorganisms cultured from human specimens. The system measures the time (in the nanosecond range) between pulsed acceleration and the corresponding detector signal, the speed is converted into an exact molecular mass. The mass-to-charge ratio of an ion is proportional to the square of its drift time. Highly abundant microbial proteins (mainly ribosomal proteins) result in a mass spectrum with characteristic mass and intensity distribution. It is specific for many bacteria and is interpreted as a molecular fingerprint to identify the test organism.

Here's an analysis of the provided text to extract the acceptance criteria and study details:

1. Table of Acceptance Criteria and Reported Device Performance

The document doesn't explicitly state "acceptance criteria" in a formal table format with numerical targets. However, based on the performance data presented, the implicit acceptance criteria for identification confidence (log(score) ≥ 2.00) are assessed. The reported performance for "Overall Isolate Performance" (Table 6) shows the aggregate performance across all claims.

2. Sample Sizes and Data Provenance

• Test Set Sample Size: 4,395 fresh and stored organisms, generating 4,399 data points for the method comparison study (which serves as the primary test set for demonstrating performance against a reference). This also includes 3,802 replicate testing results reported separately.
• Data Provenance: The method comparison study was performed at six (6) US clinical test sites and an in-house laboratory. The organisms included both fresh and stored organisms. The document indicates that due to the rarity of some organisms, replicates were tested by multiple sites.

3. Number of Experts and Qualifications for Ground Truth of Test Set

The document does not explicitly state the number of experts or their specific qualifications (e.g., "radiologist with 10 years of experience") for establishing the ground truth of the test set organisms. However, it indicates:

• "The interim reference laboratory stored all organisms included in the study and sent all organisms to the sequencing reference laboratory for sequencing and protein sequencing when requested."
• This implies that a reference laboratory, likely staffed by expert microbiologists and molecular biologists, was responsible for confirming the identity of the organisms used as ground truth, primarily through sequencing and protein sequencing.

4. Adjudication Method for the Test Set

The document does not mention a specific adjudication method like "2+1" or "3+1" for discrepancies in the test set. The ground truth was established by a "sequencing reference laboratory for sequencing and protein sequencing." This suggests that the final identification was based on these molecular methods, rather than an expert consensus process between multiple readers.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This device is an automated mass spectrometry system for identifying microorganisms. The evaluation focuses on the device's ability to identify organisms compared to a reference method (sequencing/protein sequencing), not on how it assists human readers or improves their performance.

6. Standalone (Algorithm Only) Performance

Yes, a standalone performance study was done. The entire Method Comparison section (pages 20-25) describes the performance of the MALDI Biotyper CA System (the algorithm/device) in identifying microorganisms without human intervention in the identification process other than following the described workflow. The log(score) system is an output of the algorithm.

7. Type of Ground Truth Used

The primary type of ground truth used for the test set was molecular sequencing (sequencing and protein sequencing), which is considered a highly accurate and definitive method for microorganism identification. This was handled by a "sequencing reference laboratory."

8. Sample Size for the Training Set

The document does not explicitly state the sample size for the training set. It refers to a "reference spectra library (database)" against which the test organism's spectrum is compared. This library is implicitly the training data, but its specific size or composition is not detailed in terms of number of unique isolates or spectra.

9. How the Ground Truth for the Training Set Was Established

The document states: "Calculates matches by comparing a new spectrum against each single reference entry of a reference database." It also mentions "MALDI Biotyper for Clinical Applications (MBT-CA)" as the database. While it doesn't describe the exact process for establishing ground truth for each entry within that database, it's generally understood that such reference libraries are built using highly characterized strains whose identities have been confirmed through gold-standard methods (e.g., 16S rRNA gene sequencing, whole-genome sequencing, or polyphasic taxonomy). The context implies that the internal reference library's entries serve as the established ground truth for comparison.

Ask a specific question about this device